HOME >> BIOLOGY >> NEWS
UC Davis science, engineering and technology newstips -- March

m; Andy Fell, (530) 752-4533, ahfell@ucdavis.edu.

HUMMINGBIRDS AVOID NECTAR-ROBBED FLOWERS

When hummingbirds forage for nectar in the mountains of Colorado, they avoid flowers that have already been raided by nectar-robbing bumblebees. They do this without having to see the nectar, or remember which plants they have visited before, according to postdoctoral researcher Rebecca Irwin at the University of California, Davis.

Broad-tailed and rufous hummingbirds feed on nectar from the long red flowers of scarlet gilia (Ipomopsis aggregata). The birds play an important role in pollinating the plants. But bumblebees also have a taste for nectar. The bees chew holes in the base of the flower to get at the nectar, and do not help pollinate the plants. Nectar-robbed plants are less likely to get pollinated and produce up to 50 percent less seed, said Irwin.

Irwin simulated nectar robbing by artificially removing or adding nectar to flowers, then watched hummingbirds feeding on them. The birds were less likely to visit a plant without nectar, and probed fewer flowers on plants they did visit.

Two possible explanations are that the birds use visual clues that tell them the flower is empty, or that they remember robbed flowers from previous visits, she said.

To block visual clues, she painted over the flower bases to disguise bee holes and nectar content. Despite this, the birds still went for the full flowers.

To test the bird's spatial memory, Irwin set up full and empty flowers in an aviary and let the birds get used to them. Then she moved the flowers around. The birds still went to the full flowers, without wasting energy on empty ones.

Irwin has some more theories to test on why the birds pick the right flowers. One is that their wingbeats make the flowers vibrate, and full flowers have a different frequency to empty ones. She will be testing these ideas in ne
'"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
13-Mar-2001


Page: 1 2 3 4

Related biology news :

1. Controversial UK badger killings analyzed by UC Davis expert
2. New angle needed to get pike out of Lake Davis
3. UC Davis to begin identifying eligible families for study on environmental factors in autism
4. NSF establishes center for biophotonics at UC Davis
5. UC Davis mathematician, neuroscientist win Sloan Fellowships
6. Next-generation AIDS vaccine for healthy individuals being tested for safety, tolerability at UC Davis
7. UC Davis first cloned calf born, succumbs three days later
8. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
9. UC Davis study finds breastfeeding may protect bones in teen-age mothers
10. UC Davis, Santa Barbara get $6 million to help estuaries
11. UC Davis study finds heart benefits from apples & juice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Davis science engineering and technology newstips March

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: